Acquisition of Ceva’s equine product range by Audevard Labs

Food & Agro / Healthcare
Deal type
Buy a business / Carve out
April 2016
Countries involved


Audevard Laboratories is France’s leading veterinarian laboratory dedicated to equine health. The group develops a wide range of products, including 70 drugs, as well as nutritionals and external-care products – distributing, through various veterinary and trade channels, predominantly in France.


Capitalmind advised Audevard on the acquisition of Ceva’s equine product range in Europe


Lead team

  • Nicolas Balon

    Nicolas Balon

    Partner France

What we did

We soon identified a potential deal with the French veterinary company Ceva – thanks to previous connections, we knew that its equine product range was likely considered non-core. The acquisition chimed perfectly with Audevard’s growth strategy and we reached a smooth and successful outcome within the timeframe.

Capitalmind supported Audevard Laboratories at every stage of the acquisition process: from the first preliminary talks with Ceva to the valuation, structuring, preparation, due diligence, execution and assistance in the final contract negotiations, including value maximization.